Plain-English translation of NCT06981676 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers know that children born to mothers with obesity are more likely to become overweight themselves later in life. This study is testing whether taking omega-3 fatty acid supplements (a type of healthy fat found in fish) during pregnancy can change how a baby's fat cells and immune cells develop. The goal is to see if this medication might help reduce the risk of obesity in children.
About 22–42% of childhood obesity can be traced back to having a mother who was overweight or obese during pregnancy. Scientists believe that what happens in the womb affects a child's lifelong health, but they still don't fully understand the exact biological mechanisms involved. This trial is trying to fill that gap by testing whether this medication can reverse or prevent some of those harmful effects.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be assigned to one of four groups: normal-weight pregnant women receiving standard care, normal-weight women taking omega-3 supplements, women with obesity receiving standard care, or women with obesity taking omega-3 supplements. You will take the assigned supplement (or placebo) daily during your pregnancy and provide blood samples from your baby's umbilical cord at birth so researchers can examine how the baby's fat cells and immune cells are developing.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Chile